Sonoma Pharmaceuticals Surges 72.67% on $0.41B Volume Ranking 247th in Daily Trading Activity as Mystery Drives Momentum-Driven Rally

Sonoma Pharmaceuticals (SNOA) surged 72.67% on August 14, 2025, with a trading volume of $0.41 billion, ranking 247th in daily trading activity. The sharp rally was highlighted in pre-market movers reports, noting the stock’s over 103% gain before the open.

The spike in SNOA’s price aligns with limited direct news, as broader biotech sector updates and clinical trial developments for other firms did not mention Sonoma. However, the stock’s performance suggests investor speculation or momentum-driven trading, possibly linked to broader market appetite for small-cap biotech plays amid positive sector sentiment.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The 1-day return was 0.98%, with a total return of 31.52% over 365 days. This indicates the strategy captured some short-term momentum but was subject to market fluctuations. It performed best in June 2023, with returns of 7.02%, and worst in September 2022, with a return of -4.20%. Overall, the strategy showed volatility but a positive trend, making it suitable for traders looking for short-term opportunities.